In this AJMC peer exchange program, Dr. Ryan Haumschild and a panel of experts, including Dr. Jamie Koprivnikar, Dr. Brian Mulherin, and Dr. David Dingli, discuss Paroxysmal Nocturnal ...

Background: Sodium-glucose co-transporter 2 inhibitors (SGLT2is) have proven effective in improving cardiac outcomes, including heart failure (HF) hospitalizations and cardiovascular mortality.

HealthDay News — Sodium-glucose cotransporter 2 (SGLT2) inhibitor use is an independent risk factor for falls in people with type 2 diabetes, according to a study published online March 17 in ...

The researchers identified the structure of this machine, the mitochondrial pyruvate carrier (MPC), and 50 years since its discovery, have shown how it operates like the lock on a canal to ...

The scientists found that CKi successfully reduces breast cancer cell growth. The findings and tools used in this study helped validate that inhibition of the pathway can be effective for the ...

Sodium-glucose cotransport 2 (SGLT2) inhibitors and glucagon-like peptide 1 receptor agonists (GLP-1 RAs) may be among the most important advances in decades for patients with kidney disease.

Sodium-glucose cotransporter-2 inhibitors showed similar hepatic effectiveness to glucagon-like peptide-1 receptor agonists, especially among women and younger patients, in metabolic dysfunction ...

While both sodium-glucose cotransporter-2 (SGLT2) inhibitors and glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have been associated with slower cognitive decline, few studies have directly ...

Effect of sodium-glucose cotransporter 2 inhibitor dapagliflozin on ejection fraction reduction, myocardial and renal NF-κB expression and systemic pro-inflammatory biomarkers in models of short-term ...

Synopsis Exchange of sodium for protons across cell membranes regulates intracellular pH and cell volume. Here, cryo‐EM combined with functional assays provides first insights into the structure and ...